New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Physiology - Lung cellular and Molecular Physiology

• Publication date

  2011-03-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1152/ajplung.00122.2010PMID 21131395PMCID PMC3064283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intelectin is required for IL-13-induced monocyte chemotactic protein-1 and -3 expression in lung epithelial cells and promotes allergic airway inflammation.

  2010cited by this paper
• Monocytes and macrophages as cellular targets in liver fibrosis.

  2009cited by this paper
• Coregulation in human leukocytes of the long pentraxin PTX3 and TSG-6

  2009cited by this paper
• The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis

  2009cited by this paper
• Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis.

  2009cited by this paper
• Alternative activation of macrophages: an immunologic functional perspective.

  2009cited by this paper
• Effect of IL-10 on neutrophil recruitment and survival after Pseudomonas aeruginosa challenge.

  2009cited by this paper
• Role of CC Chemokine Receptor 2 in Bone Marrow Cells in the Recruitment of Macrophages into Obese Adipose Tissue*

  2008cited by this paper
• Cellular and molecular mechanisms of fibrosis

  2008cited by this paper
• Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus.

  2008cited by this paper
• Macrophage activation and polarization.

  2008cited by this paper
• Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis.

  2008cited by this paper
• A systemic granulomatous response to Schistosoma mansoni eggs alters responsiveness of bone marrow‐derived macrophages to Toll‐like receptor agonists

  2008cited by this paper
• New concepts in the pathobiology of chronic obstructive pulmonary disease.

  2008cited by this paper
• Cellular and molecular pathology of HTS: basis for treatment

  2007cited by this paper
• Leukocyte-derived IL-10 reduces subepithelial fibrosis associated with chronically inhaled endotoxin.

  2006cited by this paper
• The role of CCL12 in the recruitment of fibrocytes and lung fibrosis.

  2006cited by this paper
• Interleukin (IL)‐4 and IL‐13 up‐regulate monocyte chemoattractant protein‐1 expression in human bronchial epithelial cells: involvement of p38 mitogen‐activated protein kinase, extracellular signal‐regulated kinase 1/2 and Janus kinase‐2 but not c‐Jun NH2‐terminal kinase 1/2 signalling pathways

  2006cited by this paper
• Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia

  2006cited by this paper
• Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis

  2006cited by this paper
• In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-β in the lung

  2006cited by this paper
• Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies?

  2006cited by this paper
• Tristetraprolin (TTP)-14-3-3 Complex Formation Protects TTP from Dephosphorylation by Protein Phosphatase 2a and Stabilizes Tumor Necrosis Factor-α mRNA*

  2006cited by this paper
• The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond.

  2006cited by this paper
• Immunoregulatory effects of regulated, lung-targeted expression of IL-10 in vivo.

  2005cited by this paper
• CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury.

  2005cited by this paper
• Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.

  2004cited by this paper
• Regulation of Found in Inflammatory Zone 1 Expression in Bleomycin-Induced Lung Fibrosis: Role of IL-4/IL-13 and Mediation via STAT-61

  2004cited by this paper
• CCL17 and IL-10 as Effectors That Enable Alternatively Activated Macrophages to Inhibit the Generation of Classically Activated Macrophages1

  2004cited by this paper
• Distinct Transcriptional Programs Activated by Interleukin-10 with or without Lipopolysaccharide in Dendritic Cells: Induction of the B Cell-Activating Chemokine, CXC Chemokine Ligand 131

  2004cited by this paper
• Global Gene Expression Profiles During Acute Pathogen-Induced Pulmonary Inflammation Reveal Divergent Roles for Th1 and Th2 Responses in Tissue Repair1

  2003cited by this paper
• Alternative activation of macrophages

  2003cited by this paper
• CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis.

  2003cited by this paper
• Transgenic Overexpression of Interleukin (IL)-10 in the Lung Causes Mucus Metaplasia, Tissue Inflammation, and Airway Remodeling via IL-13-dependent and -independent Pathways*

  2002cited by this paper
• Antifungal and Airway Remodeling Roles for Murine Monocyte Chemoattractant Protein-1/CCL2 During Pulmonary Exposure to Asperigillus fumigatus Conidia1

  2001cited by this paper
• Peripheral Blood Fibrocytes: Differentiation Pathway and Migration to Wound Sites1

  2001cited by this paper
• Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome.

  2001cited by this paper
• Protection from Pulmonary Fibrosis in the Absence of CCR2 Signaling1

  2001cited by this paper
• Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1

  2000cited by this paper
• Effect of C-C chemokine receptor 2 (CCR2) knockout on type-2 (schistosomal antigen-elicited) pulmonary granuloma formation: analysis of cellular recruitment and cytokine responses.

  1999cited by this paper
• Interleukin 10 Increases CCR5 Expression and HIV Infection in Human Monocytes

  1998cited by this paper
• RANTES and Monocyte Chemoattractant Protein–1 (MCP-1) Play an Important Role in the Inflammatory Phase of Crescentic Nephritis, but Only MCP-1 Is Involved in Crescent Formation and Interstitial Fibrosis

  1997cited by this paper

• Macrophages on demand: How tissue trauma shapes their role

  2026cites this paper
• High-throughput bioprinted 3D cultures for probing host-pathogen interactions in bioinspired microenvironments.

  2026cites this paper
• Thiazolidine derivative (LPSF/CR-35) modulates the production of IL-17A, IL-10, IL-4, TFN, CCL2 and CXCL8 in PBMC from systemic sclerosis patients

  2025cites this paper
• Role of CCL2/CCR2 axis in pulmonary fibrosis induced by respiratory viruses.

  2025cites this paper
• Unraveling the Interactive Role of Mitochondrial Dysfunction in Promoting Macrophage Polarization in Pulmonary Fibrosis

  2025cites this paper
• The role of oxidative stress-related genes in idiopathic pulmonary fibrosis

  2025cites this paper
• Macrophages and Pulmonary Fibrosis.

  2025cites this paper
• Cellular crosstalk in fibrosis: Insights into macrophage and fibroblast dynamics

  2025cites this paper
• Mitochondrial respiratory chain deficiency is associated with an impaired skeletal muscle regenerative response and fibrosis in older men with HIV

  2025cites this paper
• Effects of Active Chronic Cigarette-Smoke Exposure on Circulating Fibrocytes

  2024influential citation
• M2 macrophage‐derived paracrine factor TNFSF13 affects the fibrogenic alterations in endothelial cells and cardiac fibroblasts by mediating the NF‐κB and Akt pathway

  2024cites this paper
• The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin-Induced Lung Fibrosis Model in Mice

  2024cites this paper
• Icariside II modulates pulmonary fibrosis via PI3K/Akt/β-catenin pathway inhibition of M2 macrophage program.

  2024cites this paper
• Prospective Variation of Cytokine Trends during COVID-19: A Progressive Approach from Disease Onset until Outcome

  2024cites this paper
• Evidence of alveolar macrophage metabolic shift following SBRT-induced lung fibrosis in mice.

  2024cites this paper
• IL-10 mediates pleural remodeling in systemic lupus erythematosus

  2024cites this paper
• Dysregulation of TNF‐induced protein 3 and CCAAT/enhancer‐binding protein β in alveolar macrophages: Implications for systemic sclerosis‐associated interstitial lung disease

  2024cites this paper
• Nanoformulated CHO-rPb27 vaccine enhances immunity and controls infection, mitigating lung inflammation and dysfunction during experimental Paracoccidioidomycosis in mice.

  2024cites this paper
• Inflammatory Markers Involved in the Pathogenesis of Dupuytren's Contracture.

  2024cites this paper
• Effects of amber LED on inflammatory and regulatory monocytes and lymphocytes.

  2024cites this paper
• Biosensor Detection of COVID-19 in Lung Cancer: Hedgehog and Mucin Signaling Insights.

  2023cites this paper
• NFATc3 Promotes Pulmonary Inflammation and Fibrosis by Regulating Production of CCL2 and CXCL2 in Macrophages

  2023cites this paper
• A Subset of Breg Cells, B10 Cells, Contribute to the Development of Radiation-induced Pulmonary Fibrosis.

  2023cites this paper
• Immunometabolism at the Heart of Cardiovascular Disease

  2023cites this paper
• Peripheral Immunophenotype in IgG4-Related Disease and Its Association with Clinical Phenotypes and Disease Activity

  2023cites this paper
• Bufotalin attenuates pulmonary fibrosis via inhibiting Akt/GSK-3β/β-catenin signaling pathway.

  2023cites this paper
• A systematic review of the research progress of traditional Chinese medicine against pulmonary fibrosis: from a pharmacological perspective

  2023cites this paper
• Identifying dysregulated immune cell subsets following volumetric muscle loss with pseudo-time trajectories

  2023cites this paper
• Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis

  2023cites this paper
• Possible cancer-causing capacity of COVID-19: Is SARS-CoV-2 an oncogenic agent?

  2023cites this paper
• Can antibody conjugated nanomicelles alter the prospect of antibody targeted therapy against schistosomiasis mansoni?

  2023cites this paper
• Regulatory T cell and macrophage crosstalk in acute lung injury: future perspectives

  2023cites this paper
• In Vivo Delivery of M0, M1, and M2 Macrophage Subtypes via Genipin-Cross-Linked Collagen Biotextile

  2022cites this paper
• Destructive fibrotic teamwork: how both microenvironment stiffness and profibrotic interleukin 13 impair alveolar macrophage phenotype and function.

  2022cites this paper
• Inhibition of ROCK ameliorates pulmonary fibrosis by suppressing M2 macrophage polarisation through phosphorylation of STAT3

  2022cites this paper
• The emerging roles of interstitial macrophages in pulmonary fibrosis: A perspective from scRNA-seq analyses

  2022influential citation
• PCSK9 Suppresses M2-Like Tumor-Associated Macrophage Polarization by Regulating the Secretion of OX40L from Hepatocellular Carcinoma Cells

  2022cites this paper
• Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play

  2022cites this paper
• Molecular mechanisms underlying hyperoxia-induced lung fibrosis.

  2022cites this paper
• Pathophysiological Changes in Rhesus Monkeys with Paraquat-Induced Pulmonary Fibrosis

  2022cites this paper
• Evaluation of the correlation between D-dimer and total L-fucose, fucose binding protein and fucose binding lipids in type 2 diabetes patients infected with COVID-19

  2022cites this paper
• IL10 trains macrophage pro-fibrotic function after lung injury.

  2022cites this paper
• Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches

  2022cites this paper
• Allies or enemies? The effect of regulatory T cells and related T lymphocytes on the profibrotic environment in bleomycin-injured lung mouse models

  2022cites this paper
• Evaluation of CXCL 10 and IL-10 in COVID-19 pneumonia

  2022cites this paper
• Molecular Mimicry Analyses Unveiled the Human Herpes Simplex and Poxvirus Epitopes as Possible Candidates to Incite Autoimmunity

  2022cites this paper
• Monocyte chemotactic protein (MCP)-1 (CCL2) and its receptor (CCR2) are elevated in chronic heart failure facilitating lung monocyte infiltration and differentiation which may contribute to lung fibrosis.

  2022cites this paper
• Aspirin-Triggered Resolvin D1 Reduces Chronic Dust-Induced Lung Pathology without Altering Susceptibility to Dust-Enhanced Carcinogenesis

  2022cites this paper
• Clinical, radiological, and histological correlation in diagnosis of pulpitis

  2022cites this paper
• Long-term respiratory exposure to amorphous silica nanoparticles promoted systemic inflammation and progression of fibrosis in a susceptible mouse model.

  2022cites this paper
• Single-cell transcriptomics reveals immune dysregulation mediated by IL-17A in initiation of chronic lung injuries upon real-ambient particulate matter exposure

  2022cites this paper
• Overview of Cytokines and CoViD19

  2022cites this paper
• Clinical and Immunological Markers of Pulmonary Impairment Among People With HIV in India

  2022cites this paper
• Implications of the Immune Landscape in COPD and Lung Cancer: Smoking Versus Other Causes

  2022cites this paper
• Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice

  2021cites this paper
• Remodeling tumor microenvironment with nanomedicines.

  2021cites this paper
• The War Against SARS-CoV-2: The Immune Giant Collapsing Under Its Own Rampaging Cytokine Storm

  2021cites this paper
• The understanding of the immunopathology in COVID-19 infection

  2021cites this paper
• Evolving Roles of Muscle-Resident Fibro-Adipogenic Progenitors in Health, Regeneration, Neuromuscular Disorders, and Aging

  2021cites this paper
• Regulatory Immune Cells in Idiopathic Pulmonary Fibrosis: Friends or Foes?

  2021cites this paper
• Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity

  2021cites this paper
• New Insights into Pathomechanisms and Treatment Possibilities for Lung Silicosis

  2021cites this paper
• Ameliorative Effect of Thymoquinone-Loaded PLGA Nanoparticles on Chronic Lung Injury Induced by Repetitive Intratracheal Instillation of Lipopolysaccharide in Rats

  2021cites this paper
• COVID-19 Thrombosis: Bridging the Old and New Concepts

  2021cites this paper
• TSC1 Affects the Process of Renal Ischemia-Reperfusion Injury by Controlling Macrophage Polarization

  2021cites this paper
• Protective mechanism of flavonoids of Oxytropis falcata bunge against IPF

  2021cites this paper
• Distinct roles of KLF4 in mesenchymal cell subtypes during lung fibrogenesis

  2021cites this paper
• High-Expressed Macrophage Scavenger Receptor 1 Predicts Severity Clinical Outcome in Transplant Patient in Idiopathic Pulmonary Fibrosis Disease

  2021cites this paper
• Total coumarin derivates from Hydrangea paniculata attenuate renal injuries in cationized-BSA induced membranous nephropathy by inhibiting complement activation and interleukin 10-mediated interstitial fibrosis.

  2021cites this paper
• Macrophages in Lung Injury, Repair, and Fibrosis

  2021cites this paper
• Role of interleukins in the pathogenesis of pulmonary fibrosis

  2021cites this paper
• Protective Effects of Lactoferrin against SARS-CoV-2 Infection In Vitro

  2021cites this paper
• Isolation and Characterization of Heparan Sulfate from Human Lung Tissues

  2021cites this paper
• Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19

  2021cites this paper
• Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes

  2021cites this paper
• Mitigation of Radiation-Induced Lung and Heart Injuries in Mice by Oral Sepiapterin after Irradiation

  2021cites this paper
• Matrix metalloproteinases inhibitors in idiopathic pulmonary fibrosis: Medicinal chemistry perspectives.

  2021cites this paper
• Interpreting Immunoregulation in Lung Fibrosis: A New Branch of the Immune Model

  2021cites this paper
• Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases

  2021cites this paper
• Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis

  2021cites this paper
• Biochar Nanozyme from Silkworm Excrement for Scavenging Vapor-Phase Free Radicals in Cigarette Smoke.

  2021cites this paper
• Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities.

  2020cites this paper
• Effectiveness of Platelet-Rich Plasma in the Prevention of Chlamydia-Induced Hydrosalpinx in a Murine Model

  2020cites this paper
• Cadherin-11 and cardiac fibrosis: A common target for a common pathology.

  2020cites this paper
• Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy

  2020cites this paper
• Folate and macrophage folate receptor-β in idiopathic pulmonary fibrosis disease: the potential therapeutic target?

  2020cites this paper
• Cytokine Storm in COVID-19: An Overview, Mechanism, Treatment Strategies, and Stem Cell Therapy Perspective

  2020cites this paper
• Integration of transcriptomics, proteomics and metabolomics identifies biomarkers for pulmonary injury by polyhexamethylene guanidine phosphate (PHMG-p), a humidifier disinfectant, in rats

  2020cites this paper
• The rationale for targeting the JAK/STAT pathway in scleroderma-associated interstitial lung disease.

  2020cites this paper
• COVID-19 and diabetes mellitus: how one pandemic worsens the other

  2020cites this paper
• The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection Fraction

  2020cites this paper
• Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments

  2020cites this paper
• The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis

  2020cites this paper
• Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis

  2020cites this paper
• Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging

  2020cites this paper
• Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice

  2020cites this paper
• Statin therapy in COVID-19 infection: much more than a single pathway

  2020cites this paper
• Multimodal imaging and electroretinography highlights the role of VEGF in the laser-induced subretinal fibrosis of monkey.

  2020cites this paper
• Footprint of the COVID-19 Pandemic in India: A Study of Immune Landscape and Other Factors Shielding Mortality

  2020cites this paper
• Fibrocyte accumulation in the lungs of cystic fibrosis patients.

  2020cites this paper